2000
DOI: 10.1210/en.141.3.938
|View full text |Cite
|
Sign up to set email alerts
|

Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone

Abstract: A number of studies from different laboratories clearly show that cells of the immune system produce a GH molecule indistinguishable from that produced in the pituitary. A more recent finding from our studies suggests that monocytes use the same first exon and promoter sequence for the expression of lymphocyte GH as that reported for the expression of pituitary GH. In this report we have extended these results by determining that two members of the SP family of transcription factors, SP1 and SP3, bind to the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2002
2002
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…It should also be noted that SP-1 binding may also increase after stress and confer resistance to oxidative stress [49]. In a previous report, we showed that SP transcription factors bind to the region at −138/−133 bp containing a GGGAGG motif in the GH promoter and appeared to inhibit GH promoter luciferase activity in the P-388 monocyte cell line [50]. Although this result may initially appear puzzling, the two studies were done in different cell lines and under different experimental conditions.…”
Section: Discussionmentioning
confidence: 99%
“…It should also be noted that SP-1 binding may also increase after stress and confer resistance to oxidative stress [49]. In a previous report, we showed that SP transcription factors bind to the region at −138/−133 bp containing a GGGAGG motif in the GH promoter and appeared to inhibit GH promoter luciferase activity in the P-388 monocyte cell line [50]. Although this result may initially appear puzzling, the two studies were done in different cell lines and under different experimental conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is reasonable to expect they also compete for binding to promoters containing GC-boxes. In fact, these two factors have been shown to display differential activity, including parallel or opposing transcription effects depending on the promoter (Conn et al 1996, Kennett et al 1997, Hata et al 1998, Hoppe & Francone 1998, Nielsen et al 1998, Rajakumar et al 1998, Yajima et al 1998, Merchant et al 1999, Vines & Weigent 2000. Cell-type-specific levels of Sp1 and Sp3 variants have the potential to be an important mode of regulating the contribution of Sp1 to promoter activity.…”
Section: Role Of Sp1 In Basal Transcriptionmentioning
confidence: 99%
“…Sp1 and Sp3 compete for binding to GC-boxes and display differential activity, including parallel or opposing transcription effects depending on the promoter [46][54] or cell type [29]. That Sp1 and Sp3 bind to hres regulatory sequences was further confirmed by site directed mutagenesis of Sp1 binding site and ChIP assay.…”
Section: Discussionmentioning
confidence: 83%